Prof Pradip Sinha, Co-Founder of InvivoD Solutions and Professor at IIT Kanpur will speak at the 15th Biopharma India conference in Mumbai on 19-20 September 2017.

From Idea to Commercialisation: 10 minutes with Pradip Sinha

Emily Event News Leave a Comment

University is a great source of innovation with huge potential to commercialise ideas to feasible products. To bring you true innovators at the 15th BioPharma India conference this 19-20 September, we reviewed all possible early stage biotech companies in India, including spinoff from India’s most reputable academic institutions and incubation centers. One of the shortlisted companies is InvivoD Solutions, a spin off …

Rohan and colleague at C-CAMP

Gene therapy in India: Meet Viravecs, an early stage biotech

Emily Event News Leave a Comment

Immuno-oncology in preventive healthcare may be a popular trend right now but it is not just big pharma’s game. We observed several interesting start ups in Asia working on finding the solution to cancer, including Viravecs from India tackling the problem from the genetics angle. We spoke with Rohan Kamat, Co-founder of Viravecs who is confirmed to speak at the …

5 Questions with Sooraj Ratnakumar

10 minutes with Swagene, an India biotech start up on precision & personalised medicine

Emily Event News Leave a Comment

Following the success of the Biotech Innovation Track at BioPharma Asia 2017 (now rebranded to Phar-East), we are delighted to introduce the same pitching format to the 15th BioPharma India 2017 in Mumbai this 19-20 September, to allow early stage, innovative Indian biotech companies to introduce their company profile and upcoming pipelines to interested investors and potential partners. One of …

Carl Firth, CEO & Founder, ASLAN pharma, Singapore

Interviewing ASLAN, a leading Singapore biotech

Emily Event News Leave a Comment

If you have been keeping a lookout for promising biotech companies in Asia to invest in, then you have probably heard about ASLAN, a Singapore based biotech company founded in 2010.  Dr Carl Firth, the CEO and founder and his team has worked tirelessly to build innovative therapeutic products focusing on treating patients in Asia, as well as several rare …

Left: Founder Dr Jane Cardosa
Center: Dr Uwe Schlokat
Right: Michelle Gan

Interview with Dr Uwe Schlokat, CEO of Sentinext Therapeutics

Emily Event News Leave a Comment

Founded in 2008, Sentinext is a Malaysian biotech company which focuses on building innovative vaccines to protect Asia populations against infectious viral diseases. Using its proprietary Virus-like particle (VLP technology), Sentinext’s trademark project is to build vaccines for Hand foot mouth disease (HFMD), a highly prevalence infection among children in Asia. We have had the opportunity to interact with its CEO …

Image taken from http://www.genomeasia100k.com/

Sustaining innovation-based biotech in the home of generics

Emily Event News Leave a Comment

India is probably one of the world’s most successful generics markets. Despite all the scandals related to quality of the generics drugs supplied to developed market, the country still remains the home of low cost, high quality generics production. We interviewed Dr C.N. Ramchand, founder of several innovative companies including Saksin Lifesciences and MagGenome to seek his rationale of going …

Imugene

Imugene’s therapeutic vaccines in treating gastric cancer

Emily Event News Leave a Comment

Gastric cancer is one of the top causes of death in Asia. More than 50% of gastric cancer cases happen in East Asia, and as the 3rd most common cancer after breast and lung cancer, it is important to develop prevention method to prevent and cure this disease. Imugene (ASX: IMU) is a clinical stage immuno-oncology company headquartered in Melbourne, Australia. …

pharma-manufacturing_645x400

Finding global GMP-certified CMOs in China

Emily Event News Leave a Comment

In-house biomanufacturing is costly. Besides the heavy infrastructure investment required, the need to efficiently manage talent, capacity, financial resources and quality often encourages pharma companies to consider outsourcing as an alternative. However,  despite the growing number of CMO and CDMO within China,  the availability of CMO providing high quality yet affordable services is lagging way behind the amount of demand within …

Dr Chang (fourth from right) and his team at Immunwork

Five Questions with Immunwork

Emily Event News Leave a Comment

The biopharma industry in Asia is an exciting one. Despite uncertainty caused by a fragmented marketplace and different regulatory systems, innovators constantly overcome market challenges and produce useful inventions which brings the development of the industry to the next greater level. Among these is Immunwork, a Taiwanese biotech company which created an invention, T-E™ , a molecule containing both targeting (T) …

In photo: CTO of Biovalence Biotech, Mr EngHuan Ung

5 questions with Biovalence, a Malaysian biotech

Emily Event News Leave a Comment

At BioPharma Asia 2017, we invite 40 Asia biotech companies to present their innovative offerings in our new Biotech Innovation track. Among the participating companies is BioValence, Malaysia. Prior to the event, we asked EngHung Ung, CTO of BioValence to give you a preview on what you will expect to hear from them at the event. Q: Who is Biovalence and how is it disrupting the …